BioSpace News Archive

Policy

Advisory - Health Canada warns Canadians about U-Dream herbal sleep-aid products after tests detect a substance similar to a prescription insomnia drug, which may pose serious health risks

Health Canada is advising Canadians that it has tested several U-Dream Lite and U-Dream Full Night herbal sleep-aid products and has found that they contain a substance similar to the prescription drug zopiclone, which may pose serious health risks.

December 23, 2019
·
3 min read
Deals

Liminal BioSciences Comments on Unusual Market Activity

Liminal BioSciences Inc., is issuing this news release in light of unusual trading activity related to the common shares of the Company on the Toronto Stock Exchange and Nasdaq.

December 23, 2019
·
3 min read
Business

NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207

NewLink Genetics Corporation announced that the company has entered into an exclusive worldwide license agreement with Ellipses Pharma Limited for the development of and rights to commercialize NLG207, a nanoparticle formulation of the topoisomerase 1 inhibitor camptothecin.

December 23, 2019
·
4 min read
Business

Emmaus Life Sciences Announces Update of its Partnership with taiba Healthcare to Expand Patient Access for Sickle Cell Disease Treatment in the Middle East and North Africa (MENA) Region

Emmaus Life Sciences, Inc. reported that it expects to receive shortly the initial purchase orders relating to taiba Healthcare’s early access program for Endari® in certain countries in the Middle East and North Africa region.

December 23, 2019
·
4 min read
Pharm Country

AdaptHealth Corp. to Present at 38th Annual J.P. Morgan Healthcare Conference

AdaptHealth Corp. announced that CEO Luke McGee is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 10:30 am PST..

December 23, 2019
·
1 min read
Deals

CEL-SCI Announces Proposed Underwritten Public Offering of Common Stock

CEL-SCI Corporation announced that it intends to offer shares of its common stock for sale in an underwritten public offering.

December 23, 2019
·
4 min read
Deals

Exicure Announces the Closing of its Offering of Common Stock

Exicure, Inc. announced the closing of its previously announced underwritten public offering of 10,000,000 shares of its common stock to the public at $2.75 per share.

December 23, 2019
·
4 min read
Deals

Bioasis Completes Bridge Financing Transaction

This News Release Is Intended for Distribution in Canada Only and Is Not Intended for Distribution to United States Newswire Services or Dissemination in the United States

December 23, 2019
·
6 min read
Policy

Teligent, Inc. Announces FDA Request for Further Data on Complex Drug

Teligent, Inc. announced its development partner has received a Complete Response Letter from the U.S. Food and Drug Administration for its abbreviated new drug application for its first complex drug indicated for an orphan disease population.

December 23, 2019
·
2 min read